2007 (Milestone):

• Launch of Brain Science Institute (BSi)
• Technology Development and Commercialization Symposium
• Pharma Alliances: Biogen, Eisai, Helsinn, Johnson and Johnson

2008 (Image):

• First BSi Working Groups and Funding
  • Awarded $21 million in grants between 2008-2014
• Learning, Arts and the Brain Summit
• Launch of Brain Night Lecture Series

2009 (Milestone):

• Creation of Center for Brain Imaging Science
• Launch of Imaging Grant Program
• Launch of BSi Cores
• First Drug Discovery Bootcamp

2010 (Research):

• Launch of Drug Discovery Initiative at Hopkins
  • 100 scientists/clinicians for novel drugs
  • 20 patents
  • 150 publications
  • $200 million federal grants
• Science of the Arts Symposium
• Beauty and the Brain Partnership with the Walters Museum
• Packard Global Annual Meeting

2011 (Research):

• Launch of Neurodegeneration Program
  • $645 million in philanthropy
  • 2 patents
  • 100 publications
  • Developed faculty base
  • Discovery of major gene for ALS and Dementia
• Science of the Arts Grants Funding
  • Awarded initial grant for creativity research led by Charles Limb, MD
  • Funded five seminal arts research proposals

2012 (Research):

• Creation of Neurocognition Program
• Neurocognition Faculty Hire: Daniel O’Connor, MA, PhD, Assistant Professor of Neuroscience
  • 14 publications
  • $4.2 million extramural funding
• SIN Grant Funding for Innovative Bridge Research Funding
• First Graduate Drug Discovery Course

2013 (Milestone):

• Launch of BSi Brain Talk Radio Show and Podcasts
• Launch of First New Gene Therapy for Dementia and ALS

2014 (Research):

• Neurocognition Faculty Hire: Gul Dolen, MD, PhD, Assistant Professor of Neuroscience
  • 12 publications
  • $4.1 million extramural funding
  • Patent pending
  • Clinical trials
• Neurocognition Faculty Hire: Jeremiah Cohen, PhD, Assistant Professor of Neuroscience
  • 10 publications
  • $3.1 million in extramural funding
• High Throughput Drug Screening Collaboration – Eisai

2015 (Milestone):

• Launch of Answer ALS - Personalized Medicine for ALS
  • $42 million nationwide program

2016 (Milestone):

• Launch of the International Arts + Mind Lab (IAM Lab)
• Neurodegeneration Faculty Hire: Shuying Sun, PhD, Assistant Professor of Pathology
• Partnership with Team Gleason, Travelers Insurance

2017 (Research):

• Academic Drug Discovery Consortium Symposium
• Development of National Drug Translational Training Program with NIH
• IAM Lab Development of Impact Thinking Model
• New Johns Hopkins Drug Discovery Drug Company
  • Dracen Pharma - $41 million external investment

2018 (Milestone):

• First Clinical Trial for Gene Therapy for ALS Dementia
• Neurodegeneration Big Data Initiative
  • IBM Watson and Microsoft partnership
  • Caterpillar and American Airline partnerships
  • $150 million in grants
  • 2 patents
  • 100+ publications
• New Johns Hopkins Drug Discovery Drug Companies
  • Lorem Pharma - $1 million investment
  • Adarga - $1 million investment

2019 (Research):

• Neurodegeneration Expansion to Alzheimer’s Disease
  • Launched Answer AD - personalized stem cell tools for Alzheimer's
  • New faculty hires: Lindsey Hayes MD, PhD, Assistant Professor of Neurology; Matthew Elrick MD, PhD, Assistant Professor of Neurology
• Launch of IAM Lab Dialog Series
• IAM Lab Launch of NeuroArts Blueprint with the Aspen Institute

2020 (Milestone):

• IAM Lab Launch of COVID-19 NeuroArts Field Guide
• IAM Lab Launch of the Arts for Health Equity and Social Justice Series
• Neurodegeneration Faculty Hire: Sarah Berth MD, PhD, Assistant Professor of Neurology
• Johns Hopkins Drug Discovery Hire: Jack Wei, PhD, Director, Biochemistry and Assay Development
• Johns Hopkins Drug Discovery Celebrates First Decade
  • 160+ publications
  • 9 different drug discovery programs
  • 19 pharmaceutical partnerships
  • 15 disease foundation partnerships
  • Government funding from 14 different US agencies

2020 (Milestone):

Naming of BSi to the Johns Hopkins Pedersen Brain Science Institute.